Trump Criticizes Losers Opposing Iran Deal Amid Republican Concerns Over Geopolitical Stability UK Food System Under Scrutiny as Price Cap Proposal Sparks Industry Backlash Beyond Oil and Geopolitics Inflation Pressures Spread Across Multiple Consumer Categories SGX RegCo Gives Suspended Firms Three Years to Resume Trading or Face Delisting Toronto Blue Jays Legend Passes at Age Age Unknown from Source Park Medi World Shares Surge to Record High After Acquisition Update Brookfield Renewable Corporation BEPC Q1 2026 Earnings WiderthanExpected Loss Amid Operational Headwinds SNSE Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Stage C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution Bloom Energy Q1 2026 Earnings Massive EPS Surprise Highlights Operational Efficiency BTMD Q1 2026 Earnings EPS Beats Estimates by 2371 Amid Revenue Discrepancy INTS Q1 2026 Earnings EPS Beat Despite PreRevenue Status Shares Edge Higher ALX Oncology ALXO Edges Higher Amid Modest Buying Interest Resistance at 206 in Focus Houlihan Lokey HLI Holds Steady Near Support Amid Modest Pullback Nautilus Biotechnology NAUT Holds Steady at 254 as Stock Consolidates Near Key Levels Comcast Holdings ZONES CCZ Holds Steady at 639 as Consolidation Persists Moodys Corporation MCO Advances 084 as Price Holds Above Key Support Level Reid Hoffman Raises 246 Million for AI CancerResearch Startup Manas AI PNNT Q1 2026 Earnings Earnings Miss Amid Stable Portfolio Performance Polaryx Therapeutics PLYX Slips 271 as Stock Tests Key Support Near 238 LOMA Q1 2026 Earnings Strong EPS Delivery Amidst Macro Uncertainty C3ai Q1 2026 Earnings WiderThanExpected Loss and Tepid Market Reception VIPS Q1 2026 Earnings EPS Misses Estimates Shares Dip VGZ Q1 2026 Earnings Negative EPS Reflects Development Stage Stock Rises on Project Milestones KW Q1 2026 Earnings Strong EPS Surprise Amidst Challenging Market Stratasys SSYS Q1 2026 Earnings NarrowerThanExpected Loss Sparks Positive Reaction Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage